TickerFacts.

Axim Biotechnologies, Inc. (AXIM): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$7.66M
As of 2023-12-31
$1.57M2010-12-31: $02011-12-31: $10.2K2012-12-31: -$4.7K2013-12-31: -$93.9K2014-12-31: -$580.7K2015-12-31: -$1.70M2016-12-31: -$2.37M2017-12-31: -$6.28M2018-12-31: -$6.08M2019-12-31: -$6.76M2020-12-31: $1.57M2021-12-31: -$2.34M2022-12-31: -$4.83M2023-12-31: -$7.66M-$7.66M
2010-12-31 Shareholders' Equity (USD) 2023-12-31
Period endedShareholders' EquityChange YoYSource filing
2023-12-31-$7.66Mn/m2024-04-16, Balance as of period end
2022-12-31-$4.83Mn/m2024-04-16, Balance as of period end
2021-12-31-$2.34Mn/m2024-04-16, Balance as of period end
2020-12-31$1.57Mn/m2022-04-19, Balance as of period end
2019-12-31-$6.76Mn/m2021-04-26, Balance as of period end
2018-12-31-$6.08Mn/m2020-05-20, Balance as of period end
2017-12-31-$6.28Mn/m2019-04-08, Balance as of period end
2016-12-31-$2.37Mn/m2017-09-14, Balance as of period end
2015-12-31-$1.70Mn/m2017-09-14, Balance as of period end
2014-12-31-$580.7Kn/m2016-04-18, Balance as of period end
2013-12-31-$93.9Kn/m2015-04-14, Balance as of period end
2012-12-31-$4.7Kn/m2014-03-04, Balance as of period end
2011-12-31$10.2Kn/a2013-04-15, Balance as of period end
2010-12-31$0n/a2012-05-01, Balance as of period end